Sign up United Kingdom
Esperion Therapeutics Inc (NASDAQ:ESPR)

Esperion Therapeutics Inc (NASDAQ:ESPR)

Share Price
$ 48.47
2 (4.30 %)
Market Cap
$1,299.53 m
Proactive Investors - Run By Investors For Investors

Esperion Therapeutics Inc

Esperion is the Lipid Management Company passionately committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.

Bempedoic acid and the company's lead product candidate, the bempedoic acid / ezetimibe combination pill, are targeted therapies that have been shown to significantly...

52-week High/Low: $82.68 / $33.06
Sector: MSN - Healthcare & pharmaceuticals
Market Cap: $1,299.53M

Esperion Therapeutics Inc

Interactive graph

col 3
col 4
col 5
col 6

Esperion Therapeutics Inc Timeline

Market Reports Including ESPR


© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use